Below are some videos relating to the research undertaken by Dr Robin Carhart Harris.
Psychedelics: Lifting the veil | Robin Carhart-Harris | TEDxWarwick
Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment. After completing his PhD at the University of Bristol in 2009, Robin moved to Imperial College London, where he has worked for the last few years on the brain effects of LSD, psilocybin (magic mushrooms) and MDMA, conducting some pioneering brain imaging studies of these drugs. Most recently he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat major depression. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Can Magic Mushrooms Unlock Depression? | Rosalind Watts | TEDxOxford
A clinical psychologist from Imperial College describes how Magic Mushrooms (Psilocybin), when used in a therapeutic setting, have been found to be a very effective treatment for depression. In this talk she draws on her experiences as working as a therapist on the groundbreaking Psilocybin for Depression study, and introduces us to some of the patients and their stories of transformation. Dr Rosalind Watts completed her clinical psychology training at University College London. After six years of practicing psychotherapy in the NHS, she joined a clinical trial at Imperial College, investigating psilocybin (magic mushrooms) as a treatment for depression. Her research explores patients' positive views of this intriguing therapy. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Mendel Kaelen: Psychological & Neurophysiological Effects of Music in Combination with Psychedelics
Learn more and donate: http://www.maps.org/ Mendel Kaelen, PhDc The Psychological and Neurophysiological Effects of Music in Combination with Psychedelics 2017 Psychedelic Science Conference http://psychedelicscience.org/ A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
EXCLUSIVE: Could magic mushrooms treat depression? BBC Newsnight
Could the "magic" element of magic mushrooms - psilocybin - treat people with severe depression? Researchers at Imperial College have just published the results of a trial looking at exactly this. Newsnight had exclusive access to this controversial drugs trial. James Clayton reports. The film was produced and directed by David Fuller. Newsnight is the BBC's flagship news and current affairs TV programme - with analysis, debate, exclusives, and robust interviews. YouTube: https://www.youtube.com/user/BBCNewsnight Twitter: https://twitter.com/BBCNewsnight Facebook: https://www.facebook.com/bbcnewsnight Snapchat: https://www.snapchat.com/add/bbcnewsnight
Robin Carhart-Harris - Psychedelic drugs in science and medicine
New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression. Dr Robin Carhart-Harris will describe his research with these unusual compounds, which includes the first ever functional brain imaging studies with LSD and magic mushrooms. This talk was recorded at Imperial Festival 2015
Other Videos of interest
Filmed at Breaking Convention: 3rd International Conference on Psychedelic Consciousness, 10-12th July, 2015
Johns Hopkins Psilocybin Project: Psychedelics Research History & the Mystical Experience
Roland R. Griffiths, Ph.D., is Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine. His principal research focus in both clinical and preclinical laboratories has been on the behavioral and subjective effects of mood-altering drugs. His research has been largely supported by grants from the National Institute on Health and he is author of over 300 journal articles and book chapters.